Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments. The Sorrento Therapeutics segment consists of developing a portfolio of next generation treatments for three major therapeutic areas: cancer, infectious disease, and pain. The Scilex segment is largely organized around the company's non-opioid pain management operations. The company was founded by Henry H. Ji in 1989 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Sorrento Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Sorrento Therapeutics Inc market cap is $2.04M.
What is the 52-week high for Sorrento Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Sorrento Therapeutics Inc 52 week high is $0.0985 as of September 06, 2025.
What is the 52-week low for Sorrento Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Sorrento Therapeutics Inc 52 week low is $0.0001 as of September 06, 2025.
What is Sorrento Therapeutics Inc stock price today?
Sorrento Therapeutics Inc stock price today is $0.0037.
What was Sorrento Therapeutics Inc stock price yesterday?
Sorrento Therapeutics Inc stock price yesterday was $0.0036.
What is the 50-day moving average of Sorrento Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Sorrento Therapeutics Inc 50-day moving average is $0.0027.